|
Mr. Evan Myrianthopoulos has been a director of DOR since 2002 and is currently the chief financial officer (CFO) after joining the Company in November 2004 as president and acting CEO. From November 2001 to November 2004 Evan was president and founder of CVL Advisors Group Inc. a financial consulting firm specializing in the biotechnology sector. Prior to founding CVL Advisors Group Inc. Mr. Myrianthopoulos was a co-founder of Discovery Laboratories. During his tenure at Discovery from June 1996 to November 2001 Mr. Myrianthopoulos held the positions of CFO and vice president of finance where he was responsible for raising approximately $55 million in four private placements. He also helped negotiate and manage Discovery’s mergers with Ansan Pharmaceuticals and Acute Therapeutics. Prior to co-founding Discovery Mr. Myrianthopoulos was a technology associate at Paramount Capital Investments LLC a New York City-based biotechnology venture capital and investment banking firm. Prior to joining Paramount Capital Mr. Myrianthopoulos was a managing partner at a hedge fund and also held senior positions in the treasury department at the National Australia Bank where he was employed as a spot and derivatives currency trader. Mr. Myrianthopoulos holds a B.S. in economics and psychology from Emory University. | 